Abstract | BACKGROUND: Patients with diabetes mellitus have an increased risk of mortality due to cardiovascular complications. Supplementation with specific sulphur-containing amino acids is rapidly emerging as a possible therapeutic adjuvant for diabetes and associated cardiovascular complications. OBSERVATIONS: It is well-known that oxidative stress plays an important role in the pathogenesis of diabetes-induced cardiovascular disease, which is invariably associated with abnormal blood lipid profile, insulin resistance and other symptoms of metabolic syndrome. Cysteine and taurine are among the most common sulphur-containing amino acids and their cellular levels decline during diabetes that may contribute to the development of the cardiomyopathy. Although sulphur-containing agents exert multiple actions on cellular and subcellular functions in the heart, they also exhibit antioxidant properties and thus may exert beneficial effects in different pathophysiological conditions. CONCLUSION: It is concluded that reduction of oxidative stress by cysteine and taurine may serve as an important mechanism for the attenuation of diabetes-induced subcellular and functional abnormalities in the heart.
|
Authors | Paramjit S Tappia, Adriana Adameova, Naranjan S Dhalla |
Journal | Current medicinal chemistry
(Curr Med Chem)
Vol. 25
Issue 3
Pg. 336-345
(Jan 30 2018)
ISSN: 1875-533X [Electronic] United Arab Emirates |
PMID | 28685680
(Publication Type: Journal Article, Review)
|
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at [email protected]. |
Chemical References |
- Amino Acids
- Antioxidants
- Sulfur
|
Topics |
- Amino Acids
(pharmacology)
- Animals
- Antioxidants
(pharmacology)
- Diabetes Mellitus
(metabolism, physiopathology)
- Diabetic Cardiomyopathies
(complications, drug therapy, physiopathology)
- Humans
- Oxidative Stress
(drug effects)
- Sulfur
(pharmacology)
|